Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study of Rimonabant 20 mg Daily for the Treatment of Non-Diabetic Patients with Non-Alcoholic Steatohepatitis (NASH)
Koch, Alvaro
(PI)
Internal Medicine
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
7/7/08
→
6/30/11
View all
View less